rs80359212, BRCA2

N. diseases: 11
Source: ALL
Disease N. SNPs d DSI v DPI v Chr Position Consequence Alleles Class AFEXOME AFGENOME Score vda EI vda N. PMIDs First Ref. Last Ref.
Hereditary Breast and Ovarian Cancer Syndrome
2117 0.763 0.320 13 32394814 stop gained C/T snv 1.2E-05 4.2E-05 0.700 1.000 18 1990 2015
Neoplastic Syndromes, Hereditary
CUI: C0027672
Disease: Neoplastic Syndromes, Hereditary
6387 0.763 0.320 13 32394814 stop gained C/T snv 1.2E-05 4.2E-05 0.700 1.000 13 2000 2017
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
2633 0.763 0.320 13 32394814 stop gained C/T snv 1.2E-05 4.2E-05 0.700 1.000 5 2000 2014
Mammary Neoplasms
CUI: C1458155
Disease: Mammary Neoplasms
385 0.763 0.320 13 32394814 stop gained C/T snv 1.2E-05 4.2E-05 0.700 1.000 1 2016 2016
FANCONI ANEMIA, COMPLEMENTATION GROUP D1
37 0.763 0.320 13 32394814 stop gained C/T snv 1.2E-05 4.2E-05 0.700 0
GLIOMA SUSCEPTIBILITY 3
CUI: C2751641
Disease: GLIOMA SUSCEPTIBILITY 3
22 0.763 0.320 13 32394814 stop gained C/T snv 1.2E-05 4.2E-05 0.700 0
Malignant neoplasm of breast
CUI: C0006142
Disease: Malignant neoplasm of breast
3417 0.763 0.320 13 32394814 stop gained C/T snv 1.2E-05 4.2E-05 0.700 0
Malignant neoplasm of prostate
CUI: C0376358
Disease: Malignant neoplasm of prostate
1082 0.763 0.320 13 32394814 stop gained C/T snv 1.2E-05 4.2E-05 0.700 0
Medulloblastoma
CUI: C0025149
Disease: Medulloblastoma
115 0.763 0.320 13 32394814 stop gained C/T snv 1.2E-05 4.2E-05 0.700 0
Nephroblastoma
CUI: C0027708
Disease: Nephroblastoma
125 0.763 0.320 13 32394814 stop gained C/T snv 1.2E-05 4.2E-05 0.700 0
PANCREATIC CANCER, SUSCEPTIBILITY TO, 2
21 0.763 0.320 13 32394814 stop gained C/T snv 1.2E-05 4.2E-05 0.700 0